Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

Share Price is delayed by 15 minutes
Get Live Data
0.725    0.00 (0.00%)
Bid:
0.70
Ask:
0.75
Spread: 0.05 (7.143%)
Market Cap: £3.24m
THRU Live PriceLast checked at - London Stock Exchange

Intraday Thruvision Grp Share Chart

Director Share Dealing

20 Apr 2022 07:00

RNS Number : 6670I
Thruvision Group PLC
20 April 2022
 

20 April 2022

 

Thruvision Group plc

 

("Thruvision" or the "Company")

 

Director Share Dealing

 

Thruvision (AIM:THRU), the leading provider of "safe distance" people-screening technology to the international security market, announces that on 19 April 2021, Katrina Nurse, a Non-Executive Director of Thruvision, purchased 67,000 ordinary shares in the Company at a price of 29.9p. In addition, Mark Nurse, the husband of and accordingly a Closely Associated Person to Katrina Nurse, also purchased 67,000 ordinary shares in the Company at a price of 29.9p.

 

Following this transaction, the beneficial shareholding holding in the Company of Katrina Nurse and her closely Associated Persons is 134,000 ordinary shares, representing 0.09% of the Company's total issued share capital and total voting rights.

 

The notifications below, made in accordance with the requirements of the Market Abuse Regulation, provides further detail:

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Katrina Nurse

2.

Reason for the notification

(a)

Position/status

Non-Executive Director

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Thruvision Group plc

(b)

LEI

213800IZG9GM6G2TZE04

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.01 each

(b)

Identification code of the Financial Instrument

GB00B627R876

(c)

Nature of the transaction

purchase of shares

 

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

29.9p

67,000

 

 

 

(e)

Aggregated information

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

19 April 2022

(g)

Place of the transaction

London Stock Exchange

 

 

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Mark Nurse husband of Katrina Nurse

2.

Reason for the notification

(a)

Position/status

Closely Associated Person of Katrina Nurse a Non-Executive Director

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Thruvision Group plc

(b)

LEI

213800IZG9GM6G2TZE04

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.01 each

(b)

Identification code of the Financial Instrument

GB00B627R876

(c)

Nature of the transaction

purchase of shares

 

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

 

 

29.9p

67,000

 

 

 

(e)

Aggregated information

- Aggregated volume

- Price

N/A

(f)

Date of the transaction

19 April 2022

(g)

Place of the transaction

London Stock Exchange

 

 

 

For further information please contact:

 

Thruvision Group plc +44 (0)1235 425400

Tom Black, Executive Chairman

Colin Evans, Chief Executive

 

Investec Investment Banking (NOMAD & Broker) +44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

 

FTI Consulting LLP +44 (0)20 3727 1000

Matt Dixon

Tom Blundell

 

About Thruvision

Addressing the urgent need for "safe distance" people security screening in the COVID era, Thruvision is uniquely capable of detecting metallic and non-metallic items including weapons, explosives and contraband items that are hidden under clothing, at distances between 3 and 10m. Using patented passive terahertz technology, Thruvision completely removes the need for physical "pat-downs" and has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for aviation security, retail supply chain loss prevention, customs and border control, and public area security. The company has offices near Oxford and Washington DC.

 

 

www.thruvision.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKCBNFBKDFQD
Date   Source Headline
14th May 20267:00 amRNS-RNew Strategic Partnerships
7th May 202611:45 amRNSBlocklisting cancellation and interim review
7th May 202611:45 amRNSBlocklisting cancellation and interim review
8th Apr 20267:00 amRNSFY26 Trading Update
13th Mar 20267:00 amRNSUS Aviation Contract Award
13th Mar 20267:00 amRNSUS Aviation Contract Award
19th Feb 20267:00 amRNSHolding(s) in Company
19th Feb 20267:00 amRNSContract awards into UK custodial facilities
12th Feb 20267:00 amRNS-RFirst UK “Screening as a Service” Sales
22nd Jan 20267:00 amRNS-RUK Retail Distribution Contract Award
20th Jan 20267:00 amRNSSouth-East Asian Mass Transit Contract Award
12th Jan 20267:00 amRNSHolding(s) in Company
5th Jan 202611:27 amRNSAward of Share Options
19th Dec 20251:07 pmRNS-RUS Retail Distribution Contract Award
19th Dec 20251:07 pmRNS-RUS Retail Distribution Contract Award
16th Dec 20257:00 amRNSHolding(s) in Company
11th Dec 20257:00 amRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RImminent contract award
4th Dec 20257:00 amRNSHolding(s) in Company
28th Nov 20253:45 pmRNSHolding(s) in Company
26th Nov 20257:00 amRNSHolding(s) in Company
25th Nov 20257:00 amRNSInterim Results and Trading Update
6th Nov 20254:30 pmRNSBlock listing Interim Review
6th Nov 20254:30 pmRNSBlock listing Interim Review
23rd Oct 202510:53 amRNSResult of AGM
23rd Oct 20257:00 amRNSAGM Statement and Trading Update
6th Oct 20251:49 pmRNS-RNPSA Testing Update
30th Sep 202512:33 pmRNSHolding(s) in Company
29th Sep 202512:04 pmRNSHolding(s) in Company
29th Sep 202511:26 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSNotice of AGM
19th Sep 20257:00 amRNSFinal Results
15th Sep 202512:40 pmRNSHolding(s) in Company
9th Sep 20257:00 amRNS-RAdditions to Value-Added Reseller Network
1st Aug 20259:46 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSHolding(s) in Company
31st Jul 20255:00 pmRNSTotal Voting Rights
31st Jul 20252:37 pmRNSHolding(s) in Company
31st Jul 20252:01 pmRNSHolding(s) in Company
31st Jul 202510:32 amRNSHolding(s) in Company
31st Jul 20257:00 amRNSHolding(s) in Company
29th Jul 20251:54 pmRNSHolding(s) in Company
28th Jul 202510:50 amRNSResult of GM and completion of Capital Raising
28th Jul 20257:00 amRNSChange of Adviser
8th Jul 20257:00 amRNSResult of Retail Offer & Notice of General Meeting
4th Jul 20257:05 amRNSWRAP Retail Offer
4th Jul 20257:00 amRNSResult of Review & Proposed Capital Raise
2nd Jul 20257:00 amRNSMaterial Contract Award and Trading Update
23rd Jun 20251:50 pmRNSHolding(s) in Company
23rd Jun 20257:00 amRNSUpdate on Strategic Review and Formal Sale Process

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.